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Abstract
Background: Significant advances in digital technologies have meant that health care data can be collected, stored, transferred,
and analyzed for research purposes more easily than ever before. Participant-centric initiatives (PCI) are defined as “tools,
programs, and projects that empower participants to engage in the research process” using digital technologies and have the
potential to provide a number of benefits to both participants and researchers, including the promotion of public trust in medical
research, improved quality of research, increased recruitment and retention, and improved health care delivery.
Objective: The main objective of this scoping review is to describe the extent and range of PCIs across the United Kingdom,
United States, and Japan that are designed to facilitate medical research.
Methods: The methodological framework described by Levac et al will be applied to this scoping review. We will search
electronic databases (MEDLINE, EMBASE, PsychINFO, Cumulative Index to Nursing, and Allied Health Literature and CiNii),
grey literature sources, Internet search engines (Google and Bing), and hand search key journals and reference lists of relevant
articles. All digital tools and programs will be eligible for inclusion if there is a description of key features and functions that fall
within the parameters of a PCI. Only those that play a role in medical research will be included.
Results: Preliminary searches conducted in MEDLINE and EMBASE retrieved 1820 and 2322 results, respectively. The scoping
review will be completed by January 2018.
Conclusions: The scoping review will be the first to map the extent and range of PCIs currently available across the United
Kingdom, United States, and Japan, and will be the first review to contribute to a better understanding of what PCIs patients may
benefit from. Researchers and practitioners will be able to use information in this review as a guide for patients and also as a
guide for the development of future tools and programs. The results will be disseminated through a peer-reviewed publication
and conference presentations.
(JMIR Res Protoc 2017;6(12):e245)  doi: 10.2196/resprot.7407
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Introduction
Over the last few decades there have been significant advances
in digital technologies for health care provision and medical
research. These offer new and innovative ways to recruit
participants and conduct research, including the use of biobanks,
data repositories, and social media, as well as the potential for
secondary analyses of routinely collected data, such as
administrative data and medical records [1,2]. This technological
progress also means data can be stored, transferred, and analyzed
more easily than ever before.
While there is vast potential for this to improve health care,
there is a growing concern for participants’ privacy, in particular
how their data is being used and who has access to it. A
traditional model of participant consent applies to the majority
of research that is conducted; therefore, it is possible that once
broad consent has been obtained, unbeknown to participants,
their data may be shared with a variety of actors [3]. These
technical advances and improved capabilities have coincided
with the recognition of the importance of involving the public
more closely in medical research, especially with regard to their
views on privacy and consent.
The traditionally paternalistic attitude to medical research is
also changing, with a shift towards a participant-centered model
where the individual takes a more “active” role in the research
process. It is believed that this approach is more ethical, can
improve the quality of the research conducted, and may enhance
the agency and control individuals have over their health and
relevant data [4]. While the evidence to support this is currently
limited, there remains a growing consensus about the importance
of adopting this approach [5].
Participant-centric initiatives (PCIs) are platforms and programs
that have been developed in order to facilitate the “active” role
participants can take in medical research. PCIs are defined as
“tools, programs, and projects that empower participants to
engage in the research process” using digital technologies [6].
The characteristics can vary greatly between PCIs, however,
the core features remain the same: the participant is placed at
the center of decision-making and the user interface enables
them to engage with the research process. Detailed explanations
of PCIs and their features have been published elsewhere [6,7].
Briefly, PCIs fall into the following broad categories: (1)
matchmaking, (2) direct-to-consumer (DTC), (3) dynamic
negotiation, and (4) citizen science.
The matchmaking category refers to digital tools and platforms
that enable individuals to connect and communicate with
researchers and identify studies in which they might be eligible
to participate, based on their personal information and
preferences. Matchmaking tools put the individual in control
of when, how, and what types of studies they are invited to
participate in.
The DTC category refers to the commercial organizations that
offer individuals a service in addition to opportunities to
communicate with researchers and ways of being involved in
research. Services can include social media networks where
individuals can interact with others who have the same
condition. Evidence suggests that peer-to-peer support has a
variety of benefits for patients, particularly for those who are
suffering from rare or stigmatizing conditions [8,9]. Other
services may include genetic testing or tools to search for
opportunities to participate in clinical trials.
Tools that were developed to give individuals greater control
of how their data is used and shared for research purposes fall
into the dynamic negotiation category. This offers participants
an alternative to the traditional broad consent model that usually
accompanies participation in medical research, enabling them
to tailor their preferences and expectations [3].
Citizen science is a form of research driven by participants
where they are heavily involved in some or all of the design,
data collection, analysis, and dissemination of the study findings.
A number of platforms have been designed to encourage this
type of community-based approach to research that engages
and involves participants at various points throughout the
process. This type of research means that citizens can direct the
research agenda to their own interests, develop their knowledge
and skill sets, and bring a range of perspectives and expertise
to a project [10].
PCIs have the potential to provide a number of benefits to both
participants and researchers, including the promotion of public
trust in medical research, improved quality of research, increased
recruitment and retention, and improved health care delivery
[7]. Because of this, we believe it is important to understand
what PCIs are currently available to researchers and potential
participants, and how they differ in terms of their key features
and functions.
The main objective of this review is to describe the variety and
prevalence of PCIs across 3 countries: United Kingdom, United
States, and Japan.
We chose these countries because they differ with regard to the
health care systems in place, the levels of engagement and
involvement patients typically have in decisions regarding
medical care and research participation, and public attitudes
towards participation in medical research [11-14].
The United Kingdom and United States are leaders at the
forefront of the patient-centric approach to health care. National
organizations, such as INVOLVE and Patient-Centered
Outcomes Research Institute (PCORI), which were set up over
the past decade, provide support and guidance to stakeholders
regarding the involvement and engagement of patients in
medical research [15], and enable more informed health care
decision-making through that research [16].
In comparison, in Japan, a paternalistic model of health care
largely remains and research indicates that there is widespread
satisfaction in this model [17]. A qualitative study conducted
in Japan (2004) indicated that members of the public often make
decisions about participating in research studies based on
whether they trust the doctor they are speaking to or not, and
described feelings of obligation when asked to participate by a
doctor they like and trust. Participants also expressed a lack of
interest in medical research; they felt it was something
disassociated from them [14].
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A survey conducted in 2009 by the National Institute of Science
and Technology Policy (NISTEP) of the Ministry of Education,
Culture, Sports, Science, and Technology (MEXT) in Japan
suggested that members of the general population are less
interested in issues regarding science compared with individuals
in the United Kingdom and United States [18]. However, a
study we conducted in Japan that explored attitudes of patients
to the potential use of digital technology for engaging with
health care and medical research revealed that patients are
interested in the use of digital platforms for this purpose [19].
So there is growing support in Japan for a more patient-centered
approach to health care and medical research [17,20], but it is
still very much in its infancy.
These differences in infrastructure and culture make for
interesting comparisons in the types of PCIs that are currently
available in the United Kingdom, United States, and Japan.
Methods
A scoping review was considered the most appropriate design
to address the aims of this study for a number of reasons. Firstly,
the aims of this review are very broad and unlike a systematic
review or meta-analysis, we are not trying to answer a specific
question, but rather “examine the extent, range, and nature of
a research activity” [21]. Secondly, a scoping review is rigorous
and requires implementing a comprehensive and systematic
approach to searching for relevant literature. The scoping review
methodological framework described by Levac et al [22] will
be applied to this scoping review. The framework is based on
the seminal work of Arksey and O’Malley [21] and comprises
the following stages: (1) identifying the research question; (2)
identifying relevant studies; (3) study selection; (4) charting the
data; (5) collating, summarizing, and reporting the results; and
(6) consultation.
Stage 1: Identifying the Research Question
This study has built on the work by Kaye et al [7], which
discussed the key features, benefits, and challenges of
implementing PCIs. We describe examples of PCIs currently
available for research purposes. Understanding the range and
features of PCIs available was deemed important as it could
inform researchers’, clinicians’, and also potential research
participants’ decisions about research. The research question
was developed by a multidisciplinary research team which
included academic researchers from a range of fields including
law, bioethics, and public health, and was refined as the research
team became more familiar with the literature.
Key Definitions
We use the term “medical research” throughout to refer to a
broad range of research that can be applied to medical
treatments, services, and settings. In addition, we refer to the
“extent and range” of PCIs throughout this protocol. By “extent”
we are referring to the prevalence of PCIs within each country
and “range” refers to the type of PCI (using the categories
described above) and the key features of each PCI included in
the study.
Research Question
Our research question is: What is the extent and range of
participant-centric initiatives available for medical research
across the United Kingdom, United States, and Japan?
Objectives
The objectives of the study are to (1) identify existing PCIs
currently used for medical research purposes across the United
Kingdom, United States, and Japan; (2) compare the number
and types of PCIs available within the United Kingdom, United
States, and Japan; (3) estimate the number of participants using
such platforms, tools, and programs across each country; (4)
where possible, identify the model of consent used; (5) identify
and describe the key features of PCIs available within each
country; and (6) identify gaps in PCI provision within the United
Kingdom, United States, and Japan.
Stage 2: Identifying Relevant Studies
To guide the search strategy a set of parameters was developed
by the research team, which included inclusion and exclusion
criteria (Textbox 1), which scientific databases to search, where
to search for grey literature, search terms to use, search
limitations applied, and which experts to consult with regard to
review findings. To verify which countries a particular PCI is
available in, we will take the following multistage approach:
(1) identify the country of origin or use reported either in the
journal article describing the PCI or directly on the website,
platform, or tool; (2) if it is not possible to identify this from
the journal article or PCI website, platform, or tool, we will
contact the organization that developed the PCI or the authors
of the journal article; (3) if we do not receive a response
detailing the country of origin/use, we will try to identify the
Web address of any Internet-based PCI (ie, ‘.co.uk’ or ‘.jp’)
and any country-specific requirements for participants to access
PCIs (ie, National Health Service [NHS] number in the United
Kingdom or social security number in the United States). In the
event that we identify PCIs that are based in one country but
available for use in another, we will report the PCI as available
in both countries. For example, some PCIs are based in the
United States, but open to a global audience, such as Patients
Like Me. This would be reported twice, as a PCI that is available
within both the United Kingdom and United States. Because
the aims of this review are broad, we felt it was beyond the
remit of this review to include all citizen science platforms,
programs, or tools. The term “citizen science” is used to describe
a wide variety of activities [10] and we have decided to take a
pragmatic approach and focus our search on matchmaking,
dynamic negotiation, and DTC PCIs only.
Search Strategy
Three systematic reviews assessing different aspects of patient
and public involvement (PPI) within health care decisions
[23-25] were used to develop the original search strategy for
this scoping review. Preliminary searches were conducted in
MEDLINE and EMBASE to further develop the search terms,
Medical Subject Headings (MeSH), and limitations used. A
specialist subject librarian was also consulted and provided
guidance on search strategy.
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Textbox 1. Inclusion and exclusion criteria.
Inclusion
• Article or website describing PCI
• Published in English language or Japanese
• Adult population (18 or more years)
• Focus on medical/health care research purposes
• Complies with PCI definition described by Anderson et al [6]
• Digital device or tool/computer program/digital platform
• Enables potential participant to take initiative within either of the following research processes:
• To connect and communicate with researchers
• To control what data is used and shared for research purposes
• Available to participants residing in the United Kingdom, United States, or Japan
Exclusion
• Platforms that enable patients to connect and communicate with other patients only
• Platforms that use data for research, but participants are not engaged or empowered by the process
• Citizen science
Search terms included a mixture of keywords and MeSH terms
using combinations of the terms listed in Textbox 2. Proximity
search functions were used to link related terms and narrow the
search. Similar searches will also be conducted in Cumulative
Index to Nursing and Allied Health Literature (CINAHL) and
Psych-Info. Equivalent terms in Japanese will be used to search
CiNii.
Due to the topic of this scoping review, it is likely that many
PCIs will exist that are not written about in scientific literature.
Therefore, we will conduct a thorough search of grey literature
to identify non-indexed relevant literature. The grey literature
search will focus on conference abstracts and PPI organization
websites. We will therefore search Open Grey (grey literature
database), Google, and Bing using the same terms listed in
Textbox 2.
We will also hand search key journals (Digital Health, The
Journal of mHealth, International Journal of Digital Health care,
and Journal of Japan Society for Health care Management), and
the reference lists of relevant articles for citations that were not
identified from the original database search.
Finally, we will contact experts within the field of PCIs and
invite them to participate as part of an expert panel. The panel
will be made up of bioethicists, clinicians, PPI experts, and
digital health specialists who reside in the United Kingdom,
United States, and Japan. The panel will be consulted to provide
feedback on our findings and to ensure that we have identified
all relevant literature.
All searches will be conducted by members of the research team
and reference management software will be used to store all
relevant literature.
Stage 3: Study Selection
The study selection process will be conducted in 2 stages. In
the first stage, one researcher in the United Kingdom will
conduct the search for English language literature and another
researcher will conduct the search for Japanese literature. Titles
and abstracts or website content will be reviewed based on the
defined inclusion and exclusion criteria. At this initial stage the
goal is to be more inclusive and articles or websites will only
be excluded if it is clear that they fall outside of the eligibility
criteria. If the reviewer is uncertain at this stage, the article or
website will be included. In the second stage, full text articles
will be obtained and 2 reviewers will independently review the
articles and websites that have been collected in the first stage.
The articles and websites will be grouped into 3 categories:
included, excluded, and uncertain. The reviewers will then
compare categories to ensure inter-rater reliability and validity.
If there are any discrepancies that cannot be resolved, a meeting
will be held with a third reviewer to discuss the articles and
websites until a consensus is reached. If a consensus cannot be
reached, the decision of the majority will be taken.
Stage 4: Charting the Data
This stage involves extracting the relevant data from included
articles and websites that will help to address the original aims
of the scoping review. A data extraction form will be developed
based on key characteristics by the research team and members
of an expert panel will be consulted to ensure that all relevant
details will be obtained.
Two researchers will then pilot the data extraction form on the
first 25 articles or websites to be included. The research team
will meet to discuss findings of the pilot to decide whether
amendments need to be made.
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Textbox 2. Search terms.
• Participant
• participant
• public
• citizen
• stakeholder
• communit*
• Engagement
• engage*
• involve*
• PPI
• citizen science
• participatory
• empower
• consult
• partner
• collaborate
• collaboratory
• crowdsourc*
• Medical research
• trial
• RCT
• research
• studies
• study
• qualitative
• quantitative
• evaluation
• observational
• cohort
• case control
• research design
• Technology
• technology
• digital
• platform
• online
• Internet
• computer
• website
• software
• program
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Textbox 3. Preliminary steps in the data extraction process.
• Researcher performing data extraction and date conducted
• Identifying characteristics of article or website (ie, author, year, title, website name, organization)
• Country of origin/use (United Kingdom, United States, or Japan)
• Description of PCI (aim, type of platform, and method of engagement)
• Approximate number of users
• Participant requirements for use such as subscription or access fee, clinician referral, participant personal identifier (ie, NHS number, social
security number, post/zip code, etc)
• Type of organization (private/public or for profit/not for profit)
Target population (general population or specific patient groups, global, or country specific)
• Nature of research conducted
• Participant invited to take part in primary research studies
• Secondary use of data already available (ie, routinely collected hospital data from medical records or data generated from discussion between
participants)
• Who will conduct the research/access data
• Commercial organizations
• Public sector/non-profit researchers
• Universities/other educational institutes
• Other
• Type of interaction
• Matchmaking
• Dynamic negotiation
• Direct-to-consumer
• Stakeholder interaction
• Participant to participant
• Participant to researcher
• Participant to clinician/health care professional
• Model of consent
• Broad consent: a participant signs up and agrees their data can be used for any research relevant
• Explicit consent: a participant’s consent is requested before each use with a study
• Dynamic consent: a participant can specify particular future uses of their data that they will allow and uses that they will not allow
• Any additional key features
• Ability to withdraw
• Control over level of contact (study invitations/follow up procedures)
• Other
This is an iterative process and a number of versions will be
developed and reviewed before the full data extraction process
can be conducted. Data extraction will be completed by 2
researchers and a random sample of articles will be chosen for
review by a third researcher to ensure validity. Preliminary steps
are shown in Textbox 3.
Stage 5: Collating, Summarizing and Reporting the
Results
The breadth of this scoping review means it is likely that a large
amount of data will be generated. In order to adequately address
the aims of this scoping review, which are to map the extent
and range of PCIs available across the United Kingdom, United
States, and Japan, the results will be presented in the following
ways: (1) we will use the Preferred Reporting Items for
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Systematic Reviews and Meta-Analysis (PRISMA) flow chart
template reporting the search process [26]; (2) results tables
presenting the key characteristics of included PCIs that will be
stratified by country and potentially also by patient groups; and
(3) a narrative analysis which will include a description of key
findings, a critical analysis of included PCIs, and summary of
gaps within PCI provision across the 3 countries of interest.
The findings will be presented in accordance with the PRISMA
reporting guidelines where appropriate. We will also consult
our expert panel members after a first draft of results has been
developed to explore whether our search strategy has identified
all key PCIs that are related to our research objectives.
Stage 6: Consultation With Expert Panel
The consultation stage of the scoping review will provide
opportunities for input from a variety of stakeholders to ensure
that the knowledge produced from the project is relevant and
accessible. We will employ an expert panel of stakeholders who
we will consult with during stages 4 and 5 to ensure we are
gathering data that is considered important, that our search
strategy has identified all relevant PCIs, and that our findings
are clear and understandable. The expert panel will be comprised
of researchers within the area of PPI, patient engagement and
health care digital technologies, clinicians, and members of
patient organizations (lay patient/public representatives). In
addition to this, the final stage of this review will ensure that
the knowledge generated as part of this study will be
disseminated to all relevant stakeholders. A lay summary of the
findings will be produced and reviewed by our patient/public
representatives. The final version will be sent to members of
the wider stakeholder community along with a full text article
of the review.
Results
Preliminary searches were conducted in November 2016.
Initially, searches were retrieving too many results, rendering
it impractical. Advice from a specialist librarian was sought and
the search strategy was refined by combining search terms that
described the study population and characteristics of PCI (ie,
participant/ patient/ public AND engagement/ involvement/
recruitment, etc). The subsequent searches were conducted in
MEDLINE and EMBASE and retrieved 1820 and 2322 results,
respectively.
The remaining stages of the proposed scoping review will be
complete in January 2018.
Discussion
The aim of this scoping review is to map the extent and range
of PCIs currently available across the United Kingdom, United
States, and Japan. This will be the first scoping review
conducted within this area and will contribute to a better
understanding of what PCIs patients may benefit from. The
rapid advances in digital technologies over the last decade have
contributed to a shift in how a lot of medical research is
approached, including the ability to link large administrative
datasets, which has led to an increase in the analysis of routinely
collected data for medical research purposes [27,28]. However,
with these benefits also comes an increase in privacy concerns
for the participants within these research studies. PCIs have the
potential to facilitate research recruitment, increase retention
rates, and build public trust with researchers by transferring
more control to participants and providing a more transparent
view of the research process. Therefore, by identifying gaps
within the current market, we hope that new and innovative
platforms will be developed to engage, empower, and involve
potential participants within the research process.
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